As of November 8, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Bio Green Med Solution, Inc. The largest reported stake is Doris Wong Sing Ee's, at 20.58%. 21 filings are on record since August 4, 2025 (Schedule 13D/A, November 13, 2025).
Sell to companies like Bio Green Med Solution, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Yap Kim Choy · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-12
- · Reporting person: FITTERS Diversified Berhad · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-12
- · Holder: Yap Kim Choy · Percent: 8.47% · SCHEDULE 13G/A
- · Holder: Kua Khai Loon · Percent: 0% · SCHEDULE 13G/A
- · Holder: Ong Yee Lung · Percent: 0% · SCHEDULE 13G/A
Bio Green Med Solution, Inc. has 21 Schedule 13D or 13G filings on record since 2025-08-04. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 20.58% | 1,111,131 | SCHEDULE 13D/A, 2025-11-13 | 2025-11-12 | |
| 0% | 0 | SCHEDULE 13D/A, 2025-08-08 | 2025-08-05 | |
| Armistice Capital, LLC | 0% | 0 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| 0% | 0 | SCHEDULE 13G/A, 2026-03-13 | 2025-12-31 | |
| 0% | 0 | SCHEDULE 13G/A, 2026-03-13 | 2025-12-31 | |
| 0% | 0 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 | |
| FITTERS Diversified Berhad | 0% | 0 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
Holding shares or following this stake? See who's behind Bio Green Med Solution, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Bio Green Med Solution, Inc. and the records around it.
Bio Green Med Solution, Inc. elsewhere on the record
- Form D filing Mar 2025
- Who owns it
Companies that share a holder
- Lazar David E. also filed stake reports on 8 other companies: HIGHWAY HOLDINGS LTD (Nov 2026), Aterian, Inc. (Sep 2026), MAINZ BIOMED N.V. (Aug 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch Bio Green Med Solution, Inc.
Get an email when Bio Green Med Solution, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Bio Green Med Solution, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Bio Green Med Solution, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bio Green Med Solution, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
25 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Yap Kim Choy | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-12 |
| FITTERS Diversified Berhad | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-12 |
The latest filing identifies Bio Green Med Solution, Inc. by CUSIP 23254L876 and gives its principal executive office as Level 10, Tower 11, Avenue 5, No. 8 Jalan Kerinchi, Kuala Lumpur (SCHEDULE 13G/A, 2026-08-12).
Purpose of Transaction (Item 4)
Doris Wong Sing Ee
Datuk Dr. Doris Wong Sing Ee purchased the shares pursuant to the Securities Purchase Agreement. In connection with the purchase, Datuk Dr. Doris Wong Sing Ee was appointed as Chief Executive Office and as an Executive Director of the Issuer. Subject to ongoing evaluation, except as set forth above, the Reporting Person has no current plans or proposals which relate to or would result in any of the following: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940; (g) Changes in the Issuer's charter, bylaws, or instruments corresponding thereto or other actions which may impede …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-11-13; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-04 | Lazar David E. | 8.18% | SCHEDULE 13D/A |
| 2025-08-08 | Lazar David E. | 0% | SCHEDULE 13D/A |
| 2025-08-14 | Armistice Capital, LLC | 0% | SCHEDULE 13G/A |
| 2025-08-18 | Kua Khai Loon | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Ong Yee Lung | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Yap Kim Choy | 9.8% | SCHEDULE 13G |
| 2025-09-02 | Yap Kim Choy | 20.76% | SCHEDULE 13G/A |
| 2025-09-02 | Kua Khai Loon | 20.76% | SCHEDULE 13G/A |
| 2025-09-02 | Ong Yee Lung | 20.76% | SCHEDULE 13G/A |
| 2025-09-16 | FITTERS Diversified Berhad | 19.99% | SCHEDULE 13G |
| 2025-10-10 | Kua Khai Loon | 16.35% | SCHEDULE 13G/A |
| 2025-10-14 | FITTERS Diversified Berhad | 14.46% | SCHEDULE 13G/A |
| 2025-10-23 | FITTERS Diversified Berhad | 7.98% | SCHEDULE 13G/A |
| 2025-10-31 | Yap Kim Choy | 14.82% | SCHEDULE 13G/A |
| 2025-11-03 | Ong Yee Lung | 11.79% | SCHEDULE 13G/A |
| 2025-11-13 | Doris Wong Sing Ee | 20.58% | SCHEDULE 13D/A |
| 2026-03-13 | Kua Khai Loon | 0% | SCHEDULE 13G/A |
| 2026-03-13 | Ong Yee Lung | 0% | SCHEDULE 13G/A |
| 2026-05-12 | Yap Kim Choy | 8.47% | SCHEDULE 13G/A |
| 2026-08-12 | Yap Kim Choy | 0% | SCHEDULE 13G/A |
| 2026-08-12 | FITTERS Diversified Berhad | 0% | SCHEDULE 13G/A |
Questions about who owns Bio Green Med Solution, Inc.
Who owns Bio Green Med Solution, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Bio Green Med Solution, Inc.: Doris Wong Sing Ee (20.58%, Schedule 13D/A, filed 2025-11-13).
When did Doris Wong Sing Ee buy into Bio Green Med Solution, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Doris Wong Sing Ee on this page is the Schedule 13D/A, filed 2025-11-13, reporting 20.58%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 21 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Bio Green Med Solution, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| March 25, 2025 | Form D, private offering | $1M sold | Form D page | Source |
| February 14, 2025 | Form D, private offering | — | Form D page | Source |
| February 14, 2025 | Form D, private offering | — | Form D page | Source |
| November 26, 2024 | Form D, private offering | $2.06M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Bio Green Med Solution, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.